This inventor holds 2 USPTO granted patents. Top assignee: Aska Pharmaceutical Co., Ltd.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Hiroya Yajima: Innovator in Nasal Administration Technologies
Introduction
Hiroya Yajima is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the area of nasal administration. With a total of 2 patents to his name, Yajima's work is recognized for its innovative approach to drug delivery systems.
Latest Patents
Yajima's latest patents focus on a powder preparation for nasal administration. This preparation contains a particulate of steroid hormones with an average particle size ranging from 50 to 300 micrometers. The formulation aims to enhance the efficacy of steroid hormones when administered nasally, providing a new avenue for treatment options.
Career Highlights
Hiroya Yajima is currently associated with Aska Pharmaceutical Co., Ltd. His work at the company has been instrumental in advancing the development of nasal drug delivery systems. His innovative approaches have garnered attention in the pharmaceutical industry, contributing to improved patient outcomes.
Collaborations
Yajima has collaborated with notable colleagues, including Koichi Minato and Tomoya Fujisawa. These collaborations have fostered a creative environment that encourages the development of cutting-edge pharmaceutical technologies.
Conclusion
Hiroya Yajima's contributions to nasal administration technologies highlight his role as a key innovator in the pharmaceutical field. His patents reflect a commitment to improving drug delivery methods, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile